دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Editorial introductions.
doi : 10.1097/ICU.0000000000000937
Volume 34(2) pgs. v-v,95-188 March 2023
Glaucoma management in patients with penetrating keratoplasty or keratoprosthesis.
Sun, Jessica A.; Manz, Sarah N.; Shen, Lucy Q.
doi : 10.1097/ICU.0000000000000924
Advances in surgical techniques and postoperative care have significantly improved rates of short-term complications following keratoplasty; however, glaucoma remains a highly prevalent long-term and potentially devastating complication for postkeratoplasty patients.
Assessment of visual field progression in glaucoma.
Chen, Rebecca I. a; Gedde, Steven J. b
doi : 10.1097/ICU.0000000000000932
Perimetry plays an important role in the diagnosis and management of glaucoma. This article discusses the assessment of visual field progression in patients with glaucoma.
Vision rehabilitation in glaucoma patients.
Shi, Angell; Salim, Sarwat
doi : 10.1097/ICU.0000000000000930
Vision rehabilitation services are important but underutilized resources for patients with glaucoma. Glaucoma and its impact on vision can affect patients' abilities to read and drive, two activities of daily living that are associated with quality of life and functional independence.
Follow-up studies of the classical landmark studies in Glaucoma.
Meier-Gibbons, Frances a; Toteberg-Harms, Marc b
doi : 10.1097/ICU.0000000000000926
It was not until the nineteen nineties that there was scientific evidence for the primary treatment concept of glaucoma, lowering intraocular pressure. The treatment concept of lowering intraocular pressure is now proven by randomized controlled clinical trials (landmark studies).
Advances in innovative delivery systems for antiglaucoma drugs.
Chen, XinYi a; Shen, Ting b
doi : 10.1097/ICU.0000000000000933
Currently, glaucoma treatment drugs are facing problems such as low bioavailability, poor patient compliance, discontinuous administration affecting the efficacy of intraocular pressure (IOP) lowering and chronic damage to the eye caused by side effects of drugs.
Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice.
Gedde, Steven J. a; Vinod, Kateki b; Prum, Bruce E. Jr. c; for the Primary Tube Versus Trabeculectomy Study Group
doi : 10.1097/ICU.0000000000000928
The Primary Tube Versus Trabeculectomy (PTVT) Study is a multicenter randomized clinical trial comparing the safety and efficacy of tube shunt surgery and trabeculectomy with mitomycin C (MMC) in eyes without previous incisional ocular surgery.
The case for standalone micro-invasive glaucoma surgery: rethinking the role of surgery in the glaucoma treatment paradigm.
Radcliffe, Nathan
doi : 10.1097/ICU.0000000000000927
To highlight progress in glaucoma therapy challenging the traditional medication-first approach and present evidence supporting early standalone surgery in the era of micro-invasive glaucoma surgery (MIGS).
Microinvasive glaucoma surgeries: critical summary of clinical trial data with and without phacoemulsification.
Aref, Ahmad A.; Parker, Paul R.; Chen, Michael Y.
doi : 10.1097/ICU.0000000000000923
To critically summarize and examine published data from randomized controlled clinical trials (RCTs) investigating the safety and efficacy of microinvasive glaucoma surgeries (MIGS) with and without cataract surgery versus cataract surgery alone.
Uveitis and glaucoma: a look at present day surgical options.
Seow, Wei Hong a; Lim, Chris Hong Long a,b,c,d; Lim, Blanche Xiao Hong a; Lim, Dawn Ka-Ann a
doi : 10.1097/ICU.0000000000000940
To review the various surgical options in the management of medically refractory glaucoma in uveitic eyes. Recent findings: Uveitic glaucoma is particularly challenging to manage.
Risk factors and management of choroidal effusions.
Ying, Stephanie a; Sidoti, Paul A. a,b; Panarelli, Joseph F. c
doi : 10.1097/ICU.0000000000000929
Choroidal effusions are recognized as a common early postoperative complication of glaucoma surgery, and although often benign, they may cause significant ocular morbidity.
Detecting disease progression in mild, moderate and severe glaucoma.
Liebman, Daniel L. a; Wen, Joanne C. b; Shen, Lucy Q. a
doi : 10.1097/ICU.0000000000000925
The purpose of this review is to examine contemporary techniques for detecting the progression of glaucoma. We provide a general overview of detection principles and review evidence-based diagnostic strategies and specific considerations for detecting glaucomatous progression in patients with mild, moderate and severe disease.
New glaucoma drainage implants available to glaucoma surgeons.
Khodeiry, Mohamed a; Sayed, Mohamed S. b
doi : 10.1097/ICU.0000000000000936
Glaucoma drainage device (GDD) implantation surgery is commonly performed by glaucoma specialists to treat complex and refractory glaucomas.
Perturbations of the ocular surface microbiome and their effect on host immune function.
Chang, Chih-Chiun Jamie a,b; Winn, Bryan J. a,c
doi : 10.1097/ICU.0000000000000931
Current literature describing the ocular surface microbiome and host immunity are reviewed alongside experiments studying perturbations of the microbiome to explore the hypothesis that disruption of a healthy microbiome may predispose the ocular surface to inflammation and infection.
